This Startup Believes Our Genes Can Help Predict Severe COVID-19 Cases

October 27, 2020 | Ellen Glover

BOSTON – GoodCell, a Waltham-based company that helps people better understand their own health, announced this week it closed on a $17.9 million funding round.

Founded in 2016, GoodCell collects users’ blood samples, then breaks them down to their cellular, DNA and plasma components. The DNA is tested for genetic predispositions to diseases, then the information and samples are stored in a biorepository for any future testing. The company says individuals retain both ownership and control over their own samples for clinical and research purposes.


Share on facebook
Share on twitter
Share on linkedin